{"id":10652,"date":"2026-10-17T00:57:07","date_gmt":"2026-10-16T21:57:07","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=10652"},"modified":"2026-10-17T00:57:07","modified_gmt":"2026-10-16T21:57:07","slug":"sutureless-aortic-valve-strong-7-year-results","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/sutureless-aortic-valve-strong-7-year-results\/","title":{"rendered":"Sutureless Aortic Valve: Strong 7-Year Results"},"content":{"rendered":"<p>Sutureless Aortic Valve: Strong 7-Year Results<\/p>\n<p>Source: EACTS 2026 | MANTRA | October 9, 2026.<\/p>\n<p>\u2022\u2060 \u2060Perceval Plus: 708 patients across 45 centers.<br \/>\n\u2022\u2060 \u206099.7% freedom from structural valve deterioration at 3\u20137 years.<br \/>\n\u2022\u2060 \u206096.6% freedom from reoperation at 4\u20137 years.<br \/>\n\u2022\u2060 \u2060Pacemaker implantation: 3.7% at 30 days.<br \/>\n\u2022\u2060 \u2060Key message: Encouraging 7-year durability and safety for a sutureless surgical AVR, potentially facilitating faster implantation and minimally invasive approaches.<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"uJFtq2y4Uz\"><p><a href=\"https:\/\/cardiovascularnews.com\/eacts-2026-positive-mid-term-results-seen-with-sutureless-aortic-valve\/\">EACTS 2026: Positive mid-term results seen with sutureless aortic valve<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"\u201cEACTS 2026: Positive mid-term results seen with sutureless aortic valve\u201d \u2014 Cardiovascular News\" src=\"https:\/\/cardiovascularnews.com\/eacts-2026-positive-mid-term-results-seen-with-sutureless-aortic-valve\/embed\/#?secret=gltu1vzpOH#?secret=uJFtq2y4Uz\" data-secret=\"uJFtq2y4Uz\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sutureless Aortic Valve: Strong 7-Year Results Source: EACTS 2026 | MANTRA | October 9, 2026. \u2022\u2060 \u2060Perceval Plus: 708 patients across 45 centers. \u2022\u2060 \u206099.7% freedom from structural valve deterioration at 3\u20137 years. \u2022\u2060 \u206096.6% freedom from reoperation at 4\u20137 years. \u2022\u2060 \u2060Pacemaker implantation: 3.7% at 30 days. \u2022\u2060 \u2060Key message: Encouraging 7-year durability and [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10652","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=10652"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10652\/revisions"}],"predecessor-version":[{"id":10653,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10652\/revisions\/10653"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=10652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=10652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=10652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}